New Diabetes Device Comparison Platform Supports Clinical Decision-making, Prescribing
April 08, 2022

DiabetesWise Pro, created at Stanford University, provides an unbranded, unbiased guide to matching diabetes technology to patient needs, access, and lifestyle.

Diabetes Technology Myths & Facts for Primary Care Practitioners
April 07, 2022

Initiating diabetes technology of any kind is a big step for patients, but also for a lot of primary care clinicians. If you have concerns, these myths and facts are for you.

Moderate Wine Intake with Food May Help Decrease T2D Risk in Adults
March 07, 2022

Moderate consumption of alcohol with food was significantly associated with a 14% lower risk of type 2 diabetes in a preliminary analysis.

FDA Grants Clearance to First Smartphone App for Programming Insulin Dosing
February 23, 2022

t:slim X2 insulin pump users can now program or cancel bolus dosing with the secure t:connect mobile app already on their phones, says Tandem Diabetes Care.

NOACs Linked to Lower Risk for Vascular Issues than Warfarin in Patients with Diabetes, Atrial Fibrillation
February 17, 2022

Researchers in Taiwan found NOACs were associated with lower hazards of diabetes complications. and death than warfarin in persons with AF and DM.

FDA Approves Eversense E3 CGM System for Use up to 6 Months
February 14, 2022

The 180-day sensor life doubles the period of continuous use and cuts in half the number of CGM removals and reinsertions, without loss of accuracy.

Blood Glucose Levels in T2D: 42 Factors that Make A Difference
February 10, 2022

These 42 factors that affect blood glucose are listed in categories including food, activity, and biological influences. Perfect information to share with your patients with T2D.

Tirzepatide Found Safe, Effective as Add-on to Stable Basal Insulin in T2D Patients Not at Goal
February 09, 2022

Tirzepatide at 3 different doses significantly improved glycemic control and promoted weight loss when added to titrated insulin in patients with type 2 diabetes.

Your T2D Patient Needs Mealtime Insulin: Counsel on Options, then Move Ahead
February 04, 2022

NYU endocrinologist Brian Levy, MD, offers perspective on keeping the transition from basal insulin to multiple daily injections as simple as possible for patient and provider.

Barriers to Intensifying Insulin in T2D Management: An Interview on Clinical Inertia
February 02, 2022

Type 2 diabetes patients-and their PCPs-may have trouble moving to basal + mealtime insulin from basal insulin alone. Endocrinologist Brian Levy, MD, offers insights.